financetom
Market
financetom
/
Market
/
Canopy Growth Higher in U.S. Trading as Q1 Loss Narrows, Revenue Advances
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Canopy Growth Higher in U.S. Trading as Q1 Loss Narrows, Revenue Advances
Aug 8, 2025 4:58 AM

07:40 AM EDT, 08/08/2025 (MT Newswires) -- Cannabis retailer Canopy Growth ( CGC ) , up near 5% in U.S. pre-market trade, on Friday said first-quarter net loss narrowed as revenue increased on higher cannabis sales.

Net loss narrowed to $41.5 million, or $0.22 per share, from $127 million, or $1.60 per share, in the previous corresponding quarter. Analysts polled by FactSet had forecast a loss of $0.23 per share.

Net revenue increased 9% to $72.1 million, beating analysts expectations of $64.5 million. The increase was due to increased Canada adult-use cannabis, Canada medical cannabis and international markets cannabis net revenue, the company said.

"We delivered strong top line growth in the first quarter of fiscal 2026, led by momentum in our Canada adult-use cannabis business where we're gaining share in high-demand categories, and steady performance across our global medical cannabis business," Chief Executive Luc Mongeau. "This reflects the early impact of our focused commercial strategy and a more disciplined execution. I'm confident we can continue to build on this momentum through the remainder of the year."

Canopy Growth ( CGC ) shares were up US$0.05, to US$1.10 in pre-market trade.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Stock Market Highlights: Sensex closes over 280 points higher, Nifty above 11,530; broader markets surge, IndusInd Bank top gainer
Stock Market Highlights: Sensex closes over 280 points higher, Nifty above 11,530; broader markets surge, IndusInd Bank top gainer
Sep 14, 2020
Stock Market Highlights: The Indian benchmark equity indices, Sensex and Nifty ended near day's high level on Tuesday led by the positive sentiment across global markets and buying sentiment in pharma space. Broader indices supported the gains, with Nifty Midcap 100 index and Nifty Smallcap 100 indices ending over 1 percent higher each. Among sectors, Nifty Pharma gained the most over 2 percent followed by Nifty Private Bank, Nifty Financial Services and Nifty IT. Nifty PSU Bank, Nifty Auto and Nifty FMCG traded in the red. IndusInd Bank and Cipla were the top gainers of the Nifty50 index while Titan and Maruti Suzuki were the top losers.
Engaging actively with home ministry; hoping for positive news in October unlock, says PVR’s Ajay Bijli
Engaging actively with home ministry; hoping for positive news in October unlock, says PVR’s Ajay Bijli
Sep 15, 2020
Speaking to CNBC-TV18, Ajay Bijli, CMD of PVR said that they are actively engaging with the home ministry.
Closing Bell: Sensex gains 287 points, Nifty ends above 11,500; Private banks, pharma stocks lead
Closing Bell: Sensex gains 287 points, Nifty ends above 11,500; Private banks, pharma stocks lead
Sep 15, 2020
The Indian benchmark equity indices, Sensex and Nifty ended higher on Tuesday led by buying in pharma and banking stocks amid positive sentiment across global markets. The Sensex ended 287.72 points or 0.74 percent higher at 39,044.35 while the Nifty gained 81.75 points or 0.71 percent to close at 11,521.80.
Centrum recommends mid-small cap stocks amidst new Sebi regulations
Centrum recommends mid-small cap stocks amidst new Sebi regulations
Sep 15, 2020
Expect mid-caps and small-caps to deliver significant returns in the next 4-6 months, said Centrum in its report.
Copyright 2023-2026 - www.financetom.com All Rights Reserved